External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness
External validation of MS-COM showed good concordance with dependent and independent sources, suggesting the model accurately predicts obesity-related complications in an overweight/obese population with normoglycaemia/prediabetes and type 2 diabetes.
Authors
- V. Foos
- David Aceituno (ORCID: https://orcid.org/0000-0002-2967-5816)
- Christopher Lübker (ORCID: https://orcid.org/0000-0003-3220-801X)
- Christopher G. Fawsitt (ORCID: https://orcid.org/0000-0003-4526-3659)
- Howard Thom (ORCID: https://orcid.org/0000-0001-8576-5552)
- Alexander Jarde (ORCID: https://orcid.org/0000-0002-2951-9741)
- Edna Keeney (ORCID: https://orcid.org/0000-0002-4763-8891)
- Edward Kayongo (ORCID: https://orcid.org/0000-0002-1372-0678)
- Sára Larsen (ORCID: https://orcid.org/0000-0002-3887-4948)
Institutions
- Pontificia Universidad Católica de Chile (CL)
- King's College London (GB)
- Novo Nordisk (Denmark) (DK)
- University of Bristol (GB)
- Health Economics and Outcomes Research (United Kingdom) (GB)
Publication Details
- Journal
- PharmacoEconomics
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1007/s40273-025-01555-3
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk